Clinical Trial

The Medacta GMK SpheriKA Post-Marketing Surveillance Study

Recruiting
View on ClinicalTrials.gov →
Summary
This is a Post-Marketing Surveillance of GMK SpheriKA knee stem prosthesis.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-07-12; most recent amendment 2025-09-23.
Trial Details
NCT Number NCT05459948
Lead Sponsor Medacta International SA
Conditions Arthropathy, Knee Replacement
Enrollment 281 participants
Start Date 2022-07-30
Primary Completion 2035-05 (estimated)
Study Completion 2035-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-29